Patrizia Mordenti
Overview
Explore the profile of Patrizia Mordenti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Orlandi E, Citterio C, Seghini P, Di Nunzio C, Mordenti P, Cavanna L
Clin Respir J
. 2017 Nov;
12(4):1747-1752.
PMID: 29115028
Background: Patients with severe thrombocytopenia are considered at risk for bleeding during invasive procedures as thoracentesis. The use of ultrasound (US) significantly reduces the rate of pneumothorax from thoracentesis, but...
12.
Peripherally Inserted Central Catheters-Improving Appropriateness With a Dedicated and Rigorous Team
Mordenti P, Oleari F, Cavanna L
JAMA Intern Med
. 2016 Aug;
176(8):1225.
PMID: 27479663
No abstract available.
13.
Orlandi E, Mordenti P, Zangrandi A, Cavanna L
Chemotherapy
. 2015 Aug;
60(5-6):321-4.
PMID: 26279275
Background: Malignant pleural effusion (MPE) is an extremely common problem affecting cancer patients with advanced disease. The current therapy for MPE is local treatment, such as thoracentesis, chemical pleurodesis, intracavitary...
14.
Mordenti P, Vecchia S, Damonti E, Riva A, Muroni M, Cordani M, et al.
Med Oncol
. 2015 Jan;
32(2):457.
PMID: 25572812
In recent years, the expenditure for cancer care is increased largely due to the increase in cancer prevalence, demographic changes and incorporation into clinical practice of new and expensive drugs....
15.
Di Cicilia R, Mordenti P, Anselmi E, Paties C, Carella E, Cavanna L
Anticancer Res
. 2014 Sep;
34(9):5083-6.
PMID: 25202095
Worldwide, gastric cancer is the fourth most commonly diagnosed type of cancer and the second most common cause of cancer-related death. Recently, it was demonstrated that 15-20% of advanced gastro-oesophageal...
16.
Cavanna L, Mordenti P, Berte R, Palladino M, Biasini C, Anselmi E, et al.
World J Surg Oncol
. 2014 Jun;
12:139.
PMID: 24886486
Background: Malignant pleural effusion (MPE) is an extremely common problem affecting cancer patients, and thoracentesis is an essential procedure in an attempt to delineate the etiology of the fluid collections...
17.
Mordenti P, Zaffignani E, Immovilli P, Nobili E, Cavanna L
Chemotherapy
. 2014 May;
59(5):385-6.
PMID: 24852190
Background: The brain is a frequent site of metastases in small-cell lung cancer. Symptoms of cerebral involvement are headache, disorientation, nausea/vomiting and seizures. Case: A man with small-cell lung cancer...
18.
Mordenti P, Di Cicilia R, Delfanti R, Capelli P, Paties C, Cavanna L
Tumori
. 2013 Dec;
99(4):e177-83.
PMID: 24326857
Background: Solitary fibrous tumors of the pleura are rare and slow-growing neoplasms originating from the mesenchymal tissue underlying the mesothelial layer of the pleura. These tumors may have an unpredictable...
19.
Mordenti P, Capuano D, Zanlari L, Achilli R, Galli M, Marazzi E, et al.
J Pain Symptom Manage
. 2013 Jul;
46(2):e6-9.
PMID: 23831125
No abstract available.
20.
Ambroggi M, Stroppa E, Mordenti P, Biasini C, Zangrandi A, Michieletti E, et al.
Int J Breast Cancer
. 2012 Oct;
2012:439023.
PMID: 23091732
Luminal gastrointestinal (GI) metastases from breast cancer are rare, reports are fragmentary and poor. The purposes of this study are to assess the gastrointestinal involvement from breast cancer in a...